An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland

por Pollock, Richard F, Meckley, Lisa M
Publicado 2018

Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials

por Meckley, Lisa M., Wu, Yanyu, Ito, Diane, Berner, Todd, McCoy, Barbara, Yel, Leman
Publicado 2020

Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats

por Martyn, Derek, Meckley, Lisa M, Miyasato, Gavin, Lim, Sangtaeck, Riebman, Jerome B, Kocharian, Richard, Scaife, Jillian G, Rao, Yajing, Corral, Mitra
Publicado 2015